European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Developing and implementing innovative Patient-Centred Care Pathways for cancer patients

Descrizione del progetto

Un percorso verso esiti migliori per pazienti e assistenti sanitari

La priorità principale delle cure contro il cancro è il trattamento del tumore;tuttavia, è altrettanto importante trattare e prendersi cura del paziente. Un approccio di cura incentrato sul paziente, che raccolga sistematicamente gli esiti riportati dal malato, tratti i sintomi e migliori le funzioni, dovrebbe essere una componente integrata della cura oncologica standard. Il progetto MyPath, finanziato dall’UE, integrerà le cure incentrate sul paziente al trattamento oncologico di routine sviluppando e attuando un’innovativa soluzione digitale che faciliti la comunicazione tra pazienti, operatori e assistenti sanitari. I percorsi di cura incentrati sul paziente di MyPath, rafforzati grazie alla tecnologia e basati sulle prove, miglioreranno significativamente la qualità e l’accesso al trattamento e alle cure, ridurranno le variazioni nella pratica clinica e ottimizzeranno le risorse in diverse configurazioni di cura contro il cancro. Ciò ridurrà l’onere emotivo ed economico correlato al cancro.

Obiettivo

In the EU, 2.7M people were diagnosed with and 1.3M died of cancer in 2020. Over 12M people have survived cancer, thanks to advances in early detection and new therapies. With higher cure rates and more patients living longer with cancer, access to patient-centred care consisting of optimal supportive, palliative, survivorship and end-of-life care becomes increasingly important. However, cancer care still has silos, and to this day, there is no technical support available that is suitable for different cultures, settings and environments.
Several randomised controlled trials have provided evidence that the integration of patient-centred care in standard oncology care results in better patient and caregiver outcomes. As yet, these findings have not translated into clinical routine.
In this project, we will develop technology-enhanced and evidence-based patient-centred care pathways, called MyPath, to be merged with tumour-centred treatments across supportive, palliative, survivorship and end-of-life care. MyPath integrates patient-reported outcomes of the OUS Eir software, to be further advanced with contributions of renowned European oncologists, ethicists, psychologists and sociologists. It will be configurated on the eHealth platform of our SME partner DNV Imatis. Its effectiveness and sustainability will be assessed in an implementation science study in 9 clinical centres across Europe. With the support of leading cancer care professional associations ESMO and EAPC, and the cancer patient organisation ECPC, we are committed to delivering the right care to the right person at the right time by the right persons.
We hypothesise that MyPath can significantly improve the quality of and access to treatment and care, reduce variations in clinical practice, and optimise resources in family, community, and hospital care settings. This will ultimately reduce the physical, emotional, and ultimately economic burden linked to cancer.

Coordinatore

OSLO UNIVERSITETSSYKEHUS HF
Contribution nette de l'UE
€ 1 439 500,00
Indirizzo
KIRKEVEIEN 166 TARNBYGGET
0450 Oslo
Norvegia

Mostra sulla mappa

Regione
Norge Oslo og Viken Oslo
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 439 500,00

Partecipanti (11)

Partner (5)